Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 15 of 15

List	Outcome	Time frame	Description
Primary	Event-free survival (EFS)	At 2 years post-hematopoietic cell transplantation (HCT)	EFS is defined as survival time following HCT without a qualifying event. Will be summarized by the Kaplan-Meier method with 95% confidence intervals.
Secondary	Event-free survival	Up to 100 days post-HCT	EFS is defined as survival time following HCT without a qualifying event. Will be summarized by the Kaplan-Meier method with 95% confidence intervals.
Secondary	Event-free survival	Up to 1 year post-HCT	EFS is defined as survival time following HCT without a qualifying event. Will be summarized by the Kaplan-Meier method with 95% confidence intervals.
Secondary	Overall survival	Up to 100 days post-HCT	Will be summarized by the Kaplan-Meier method.
Secondary	Overall survival	Up to 1 year post-HCT	Will be summarized by the Kaplan-Meier method.
Secondary	Transplant-related mortality	Up to 30 days post-HCT	Will be summarized by the Kaplan-Meier method.
Secondary	Time to platelet and neutrophil engraftment	Up to 2 years post-HCT	Will be estimated using the method of Gooley et al.
Secondary	Incidence of graft failure (primary and secondary)	Up to 100 days post-HCT	Will be estimated using the method of Gooley et al.
Secondary	Incidence of acute graft-versus-host disease	Up to 100 days post-HCT	Will be estimated using the method of Gooley et al.
Secondary	Incidence of chronic graft-versus-host disease	Up to 1 year post-HCT	Will be estimated using the method of Gooley et al.
Secondary	Incidence of chronic graft-versus-host disease	Up to 2 years post-HCT	Will be estimated using the method of Gooley et al.
Secondary	Incidence of grade II or greater organ toxicity	Up to 100 days post-HCT	Will be reported as counts with percentages.
Secondary	Incidence of hepatic sinusoidal obstruction syndrome	Up to 100 days post-HCT	Will be reported as counts with percentages.
Secondary	Incidence of central nervous system toxicities including posterior reversible encephalopathy syndrome	Up to 100 days post-HCT	Will be reported as counts with percentages.
Secondary	Incidence of infectious complications	Up to 100 days post-HCT	Will be reported as counts with percentages.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04776850/registered

API reference For AI assistants